Stay updated on TATE-PD1 Combo in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.
Latest updates to the TATE-PD1 Combo in Liver Cancer Clinical Trial page
- Check3 days agoChange DetectedThe website has updated its contact information, adding new contacts including Melissa Yarbrough and Barbara Dion, while removing Miranda Duron, and has revised to version 2.14.0.SummaryDifference2%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information on who to contact for questions about joining the study and where it is taking place, with a revision from v2.12.2 to v2.13.2.SummaryDifference3%
- Check46 days agoChange DetectedThe website has added a new feature to display the 'Last Update Posted', replacing the previous 'Last Update Posted (Estimated)' label.SummaryDifference0.1%
- Check53 days agoChange DetectedNew additions include a Phase I study on Tirapazamine Chemoembolization for hepatocellular carcinoma and updates for November 2024, while several past dates and participant details have been removed.SummaryDifference9%
- Check60 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading data in various formats and providing detailed participant and study information, while the previous version v2.12.1 has been removed.SummaryDifference6%
Stay in the know with updates to TATE-PD1 Combo in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.